1. Empagliflozin demonstrates cytotoxicity and synergy with tamoxifen in ER-positive breast cancer cells: anti-proliferative and anti-survival effects
   Ahmad Karzoon et al, 2024, Naunyn-Schmiedeberg's Archives of Pharmacology CrossRef
2. circ_000166/miR-296 Aggravates the Process of Diabetic Renal Fibrosis by Regulating the SGLT2 Signaling Pathway in Renal Tubular Epithelial Cells
   Sheng Chen et al, 2022, Disease Markers CrossRef
3. MicroRNA-486-5p Suppresses Lung Cancer via Downregulating mTOR Signaling In Vitro and In Vivo
   Lei Ding et al, 2021, Frontiers in Oncology CrossRef
4. Canagliflozin reduces cisplatin uptake and activates Akt to protect against cisplatin-induced nephrotoxicity
   Zhixia Song et al, 2020, American Journal of Physiology-Renal Physiology CrossRef